SINGLE USE TECHNOLOGIES FOR BIOPHARMACEUTICALS MARKET ANALYSIS BY TYPE, APPLICATION, REGIONS AND COMPANIES FORECAST

  2024-11-27 |   Pages: 200+ |   Report ID: MD-R-2024-11-27-26665 |   Healthcare

Historical data: 2018 - 2023

Forecast period: 2024 - 2031

Quantitative units: Revenue in USD million and CAGR from 2024 to 2031

Report coverage: Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Single Use Technologies for Biopharmaceuticals Market

Image

1.1 SCOPE OF THE REPORT

1.2 MARKET SEGMENT ANALYSIS

1.3 REGULATORY SCENARIO BY REGION/COUNTRY

1.4 MARKET INVESTMENT SCENARIO STRATEGIC

1.5 MARKET ANALYSIS BY TYPE (USD MILLION)

1.6 MARKET ANALYSIS BY APPLICATION (USD MILLION)

2.1 DRIVER, RESTRAINT, CHALLENGE AND OPPORTUNITIES ANALYSIS

  2.1.1 MARKET DRIVER ANALYSIS

  2.1.2 MARKET RESTRAINT ANALYSIS

  2.1.3 MARKET OPPORTUNITY

  2.1.4 MARKET CHALLENGES

3.1 INDUSTRY TRENDS

  3.1.1 SWOT ANALYSIS

  3.1.2 PESTEL ANALYSIS

  3.1.3 PORTER’S FIVE FORCES ANALYSIS

3.2 POTENTIAL MARKET AND GROWTH POTENTIAL ANALYSIS

4.1 COVID-19 ANALYSIS

5.1 GLOBAL SINGLE USE TECHNOLOGIES FOR BIOPHARMACEUTICALS MARKET, SALES AREA, TYPE

5.2 MERGERS & ACQUISITIONS, PARTNERSHIPS, PRODUCT LAUNCH, AND COLLABORATION IN GLOBAL SINGLE USE TECHNOLOGIES FOR BIOPHARMACEUTICALS MARKET

7.1 GLOBAL SINGLE USE TECHNOLOGIES FOR BIOPHARMACEUTICALS MARKET SIZE AND SHARE (2018-2031) (USD MILLION)

8.1 GLOBAL SINGLE USE TECHNOLOGIES FOR BIOPHARMACEUTICALS MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

8.2 GLOBAL SINGLE USE TECHNOLOGIES FOR BIOPHARMACEUTICALS MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

9.1 GLOBAL SINGLE USE TECHNOLOGIES FOR BIOPHARMACEUTICALS MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

9.2 GLOBAL SINGLE USE TECHNOLOGIES FOR BIOPHARMACEUTICALS MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

10.1 GLOBAL SINGLE USE TECHNOLOGIES FOR BIOPHARMACEUTICALS MARKET SIZE AND SHARE BY REGION (2018-2023) (USD MILLION)

10.2 GLOBAL SINGLE USE TECHNOLOGIES FOR BIOPHARMACEUTICALS MARKET SIZE AND SHARE BY REGION (2024-2031) (USD MILLION)

11.1 NORTH AMERICA SINGLE USE TECHNOLOGIES FOR BIOPHARMACEUTICALS MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

11.2 NORTH AMERICA SINGLE USE TECHNOLOGIES FOR BIOPHARMACEUTICALS MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

11.3 NORTH AMERICA SINGLE USE TECHNOLOGIES FOR BIOPHARMACEUTICALS MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

11.4 NORTH AMERICA SINGLE USE TECHNOLOGIES FOR BIOPHARMACEUTICALS MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

11.5 NORTH AMERICA SINGLE USE TECHNOLOGIES FOR BIOPHARMACEUTICALS MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

11.6 NORTH AMERICA SINGLE USE TECHNOLOGIES FOR BIOPHARMACEUTICALS MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

12.1 EUROPE SINGLE USE TECHNOLOGIES FOR BIOPHARMACEUTICALS MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

12.2 EUROPE SINGLE USE TECHNOLOGIES FOR BIOPHARMACEUTICALS MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

12.3 EUROPE SINGLE USE TECHNOLOGIES FOR BIOPHARMACEUTICALS MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

12.4 EUROPE SINGLE USE TECHNOLOGIES FOR BIOPHARMACEUTICALS MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

12.5 EUROPE SINGLE USE TECHNOLOGIES FOR BIOPHARMACEUTICALS MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

12.6 EUROPE SINGLE USE TECHNOLOGIES FOR BIOPHARMACEUTICALS MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

13.1 ASIA PACIFIC SINGLE USE TECHNOLOGIES FOR BIOPHARMACEUTICALS MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

13.2 ASIA PACIFIC SINGLE USE TECHNOLOGIES FOR BIOPHARMACEUTICALS MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

13.3 ASIA PACIFIC SINGLE USE TECHNOLOGIES FOR BIOPHARMACEUTICALS MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

13.4 ASIA PACIFIC SINGLE USE TECHNOLOGIES FOR BIOPHARMACEUTICALS MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

13.5 ASIA PACIFIC SINGLE USE TECHNOLOGIES FOR BIOPHARMACEUTICALS MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

13.6 ASIA PACIFIC SINGLE USE TECHNOLOGIES FOR BIOPHARMACEUTICALS MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

14.1 LATIN AMERICA SINGLE USE TECHNOLOGIES FOR BIOPHARMACEUTICALS MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)/p>

14.2 LATIN AMERICA SINGLE USE TECHNOLOGIES FOR BIOPHARMACEUTICALS MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

14.3 LATIN AMERICA SINGLE USE TECHNOLOGIES FOR BIOPHARMACEUTICALS MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

14.4 LATIN AMERICA SINGLE USE TECHNOLOGIES FOR BIOPHARMACEUTICALS MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

14.5 LATIN AMERICA SINGLE USE TECHNOLOGIES FOR BIOPHARMACEUTICALS MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

14.6 LATIN AMERICA SINGLE USE TECHNOLOGIES FOR BIOPHARMACEUTICALS MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

15.1 MIDDLE EAST & AFRICA SINGLE USE TECHNOLOGIES FOR BIOPHARMACEUTICALS MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

15.2 MIDDLE EAST & AFRICA SINGLE USE TECHNOLOGIES FOR BIOPHARMACEUTICALS MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

15.3 MIDDLE EAST & AFRICA SINGLE USE TECHNOLOGIES FOR BIOPHARMACEUTICALS MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

15.4 MIDDLE EAST & AFRICA SINGLE USE TECHNOLOGIES FOR BIOPHARMACEUTICALS MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

15.5 MIDDLE EAST & AFRICA SINGLE USE TECHNOLOGIES FOR BIOPHARMACEUTICALS MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

15.6 MIDDLE EAST & AFRICA SINGLE USE TECHNOLOGIES FOR BIOPHARMACEUTICALS MARKET SIZE AND SHARE BY APPLICATION (2024-2031)< (USD MILLION)/p>

16.1 Aber Instruments Ltd.

  16.1.1 COMPANY DETAILS

  16.1.2 FINANCIALS (USD MILLION)

  16.1.3 PRODUCT SUMMARY

  16.1.4 RECENT DEVELOPMENTS

16.2 Biopharma Dynamics Ltd.

16.3 Cellon S.A.

16.4 Corning Inc

16.5 Repligen Corp

16.6 General Electric Co.

16.7 Thermo Fisher Scientific Inc

16.8 Levitronix Gmbh

16.9 Malema Engineering Corp.

16.10 Omnibrx Biotechnologies Pvt. Ltd.

16.11 Parker Hannifin Corp.

16.12 Renolit Group

16.13 Sartorius AG

16.14 Terumo Cardiovascular Group

16.15 VWR International Llc

16.16 Watson-Marlow Fluid Technology Group

16.17 W.L. Gore & Associates Inc.

16.18 Adolf Kunher Ag

16.19 Advantapure Inc.

16.20 Applikon Biotechnology B.V.

18.1 METHODOLOGY

18.2 RESEARCH DATA SOURCE

  18.2.1 SECONDARY DATA

  18.2.2 KEY DATA FROM SECONDARY

  18.2.3 PRIMARY DATA

  18.2.4 KEY DATA FROM PRIMARY

  18.2.5 INDUSTRY INSIGHT FROM PROFESSIONAL LEADERS

  18.2.6 MARKET ESTIMATION

  18.2.7 MARKET ESTIMATION: TOP-DOWN AND BOTTOM-UP APPROACH

  18.2.8 LEGAL DISCLAIMER

Market Segments

By Technology
Single-Use Bioreactors
Wave-Induced Motion Single-Use Bioreactors
Stirred Single-Use Bioreactors
Single-Use Reactor with Vertically Oscillating Perforated Disc
Single-Use Bubble Column
Single-Use Hybrid Reactor
Mixing, Storage and Filling Systems
Filtration System
Dead-End Filtration
Tangential Flow Filtration (TFF)
Centrifugal Pumps
Chromatography Systems
Affinity Chromatography
Ion Exchange Chromatography
Hydrophobic Interaction Chromatography
Mixed-Mode Chromatography
Freeze and Thaw Systems
Isolators
Control Systems
Flow Measurement Systems
Temperature Measurement Systems
pH Measurement System

By Single-Use Component
Single-Use Sensors
Advantages
Piezo Sensors
Mechanical Sensors
Electrical Sensors
Optical Sensors
Electrochemical
Impedance
Amperometric
Tubing
Connectors (Separate or Molded-in), Valves, Coupling, Tri-clamps
Transfer Systems
Sampling Systems
Media Bags
2D Bags
3D Bags
Bioprocess Containers
Filter Cartridges
Other Single-Use Products

By Application
Monoclonal Antibodies
Polyclonal Antibodies
Vaccines
Blood Derivatives
Anti-cancer Drugs
Recombinant Proteins
Gene Therapy Drugs
Stem Cell and Plasma Therapies

By End User
Biopharmaceutical Companies and Contract Manufacturers
Labs and Pathology Products
Research Institutes and Academia

Companies

Aber Instruments Ltd.
Biopharma Dynamics Ltd.
Cellon S.A.
Corning Inc
Repligen Corp
General Electric Co.
Thermo Fisher Scientific Inc
Levitronix Gmbh
Malema Engineering Corp.
Omnibrx Biotechnologies Pvt. Ltd.
Parker Hannifin Corp.
Renolit Group
Sartorius AG
Terumo Cardiovascular Group
VWR International Llc
Watson-Marlow Fluid Technology Group
W.L. Gore & Associates Inc.
Adolf Kunher Ag
Advantapure Inc.
Applikon Biotechnology B.V.

BROWSE INDUSTRY

  1. Consumer Goods
  2. Healthcare
  3. Food & Beverage
  4. Heavy Industry
  5. Service Industries
  6. FMCG
  7. Life Sciences
  8. Technology & Media
  9. Machinery & Equipment

    WHY CHOOSE US

  •   PROACTIVE
  • We manage our resources 24/7 to identify issues and address them before they become problems.

  •   QUALITY & RELIABILITY
  • We are committed to providing reliable and highly accurate data with an excellent quality control system.

  •   GLOBAL OUTREACH
  • 6 Major regions and 40+ countries level analysis accomplished.

  •   COMPETITIVE PRICING
  • Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery.